hADORA2A(BALB/c)

Nomenclature

BALB/cJSmo-Adora2atm1(hADORA2A)Smoc

Cat. NO.

NM-HU-232255

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Adora2a

Model Description

The endogenous mouse Adora2a gene was replaced by human ADORA2A gene.

Validation Data

image.png

Fig.1 Detection of ADORA2A expression in thymus, spleen and brain by RT-PCR. Mouse Adora2a mRNA (387 bp) was detectable only in wild-type BALB/c mice. Human ADORA2A mRNA (159 bp) was detectable only in homozygous hADORA2A(BALB/c) knock-in mice but not in wild-type mice. Thymus, spleen and brain RNA was extracted from 13-week-old male wild-type BALB/c (WT)(n=2) and homozygous hADORA2A(BALB/c) knock-in mice (HO) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig.2 Detection of ADORA2A expression in spleen of WT BALB/c mice and hADORA2A(BALB/c) mice by FACS. hADORA2A was exclusively detectable in hADORA2A(BALB/c) mice but not in wild-type mice. Leukocytes were collected from 12-week-old male wild-type (WT) and hADORA2A mice. The cells were stimulated in vitro for 24 h with anti-mouse CD3 and anti-mouse CD28 at 0.5 μg/mL each, then analyzed by flow cytometry using an anti-human ADORA2A antibody.

Abbr. HO,  Homozygous; WT, wild type.

image.png

Fig.3 Detection of ADORA2A expression in spleen of BALB/c mice and hADORA2A(BALB/c) mice by FACS. Due to antibody cross-reactivity,mADORA2A was detectable in both hADORA2A(BALB/c) mice and wild-type mice. Leukocytes were collected from 12-week-old male wild-type (WT) and hADORA2A mice. The cells were stimulated in vitro for 24 h with anti-mouse CD3 and anti-mouse CD28, each at 0.5 μg/mL, and then analyzed by flow cytometry using an anti-ADORA2A antibody.

Abbr. HO,  Homozygous; WT, wild type.


You may also like

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more